Skip to main content
Fig. 2 | Cancer Nanotechnology

Fig. 2

From: Lipo-MGN nanoparticle hypoxia attenuation-mediated single-dose radiotherapy- and pH/ROS-responsive T1 contrast magnetic resonance imaging in hepatocellular carcinoma

Fig. 2

Cell viability by MTS assay and cell uptake analysis. A MTS assay showing the viability of Lipo-MGNs (black bar) and MGN (grey bar) in NIH3T3 cell line. B Lipo-DiD uptake in Hep-G2 cells. C MTS assay showing viability of Lipo-MGNs after radiation in HepG2 cell line. D Log-dose versus response curve of Lipo-MGNs after radiation in HepG2 cell line. MTS assay data show the mean cell viability of quadruplicate samples ± SD. A two-tailed probability value (P) < 0.05 was considered statistically significant. *P < 0.05 relative to Lipo-MGN. **P < 0.01 and ***P < 0.001 relative to the control

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us